This statistic shows the number of new drugs receiving approval status in South Korea in 2014, by therapeutic category. In that year, a total of 33 new drugs were approved for use in South Korea, five of which were anti-cancer drugs.
Number of new drugs receiving approval status in South Korea in 2014, by therapeutic category
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 USD $39 USD / Month *
in the first 12 months
Professional Account
Full access
Corporate solution including all features.
* Prices do not include sales tax.
Statistics on Pharmaceutical industry in Denmark
Position within Europe
3
Overview
5
- Premium Statistic Revenue from pharmaceutical manufacturer in Denmark 2009-2021
- Premium Statistic Pharmaceutical revenue in pharmacies in Denmark by group 2021
- Basic Statistic Distribution pharmacy revenues in Denmark by product type 2021
- Basic Statistic Revenue of most dispensed drugs at pharmacies in Denmark 2021
- Premium Statistic Share of expenditure on pharmaceuticals in Denmark by type 2021
Key players
8
- Basic Statistic Leading pharmaceutical companies in Denmark 2021, by revenue
- Basic Statistic Employment at select top pharmaceutical companies in Denmark 2021
- Basic Statistic Net sales of Novo Nordisk 2009-2021
- Basic Statistic Net profit of Novo Nordisk 2009-2021
- Basic Statistic Revenue of LEO Pharma 2009-2021
- Basic Statistic Net profit/loss of LEO Pharma 2009-2021
- Basic Statistic Revenue of Lundbeck 2009-2021
- Basic Statistic Profit and loss of Lundbeck 2009-2021
Patents and clinical trials
5
- Premium Statistic Number of European patent applications in pharmaceutical industry 2021, by country
- Basic Statistic Number of European patents granted in pharmaceuticals in 2021, by county
- Basic Statistic Monthly number of applications for clinical trials in Denmark 2020
- Basic Statistic Monthly number of valid applications for clinical trials in Denmark 2020
- Basic Statistic Number of applications for clinical trials in Denmark 2013-2021, by sponsor
Export, sales, purchase
5
- Basic Statistic Export value of medicinal and pharmaceutical products in Denmark 2010-2021
- Basic Statistic Domestic sales from the manufacture of basic pharmaceuticals in Denmark 2017-2021
- Basic Statistic Sales value of manufacture of basic pharmaceutical products in Denmark 2017-2021
- Basic Statistic Domestic purchase value of manufacture of basic pharmaceuticals in Denmark 2017-2021
- Basic Statistic Purchase value of manufacture of pharmaceutical products in Denmark 2017-2021
Further related statistics
19
- New pharmaceutical drugs in R&D pipelines in South Korea 2014, by therapeutic area
- U.S. NDA/BLA filing approval for new drugs in select disease areas 2006-2015
- U.S. drug development phase I to approval success rates 2011-2020 by disease area
- NDA/BLA filing to FDA approval times for new drugs in select disease areas 2011-2020
- Sales of the top pharmaceutical therapeutic areas
- Sales growth of pharmaceutical therapeutic areas
- Pharmaceutical industry - sales growth by therapeutic classes
- Number of active clinical trials and studies in Australia by therapeutic class 2014
- Distribution of U.S. pharma licensing deals by therapeutic area 2016
- Number of biological drugs approved Japan 2012-2021
- Number of quasi-drugs approved by PMDA Japan FY 2012-2020
- Number of BTC and OTC drugs approved by PMDA Japan FY 2012-2020
- Number of in vitro diagnostics approved by PMDA Japan FY 2012-2020
- Number of biosimilars approved by PMDA Japan 2010-2019
- Number of NME approved Japan 2012-2021
- Number of clinical trials for new drugs in South Korea 2010-2020
- U.S. drug development phase II success rates 2011-2020, by disease area
- Number of FDA approvals for CAR-T cell therapies 2012-2024
- Valid certificates (CEPs) for API quality worldwide by region 2020
Further Content: You might find this interesting as well
Statistics
- New pharmaceutical drugs in R&D pipelines in South Korea 2014, by therapeutic area
- U.S. NDA/BLA filing approval for new drugs in select disease areas 2006-2015
- U.S. drug development phase I to approval success rates 2011-2020 by disease area
- NDA/BLA filing to FDA approval times for new drugs in select disease areas 2011-2020
- Sales of the top pharmaceutical therapeutic areas
- Sales growth of pharmaceutical therapeutic areas
- Pharmaceutical industry - sales growth by therapeutic classes
- Number of active clinical trials and studies in Australia by therapeutic class 2014
- Distribution of U.S. pharma licensing deals by therapeutic area 2016
- Number of biological drugs approved Japan 2012-2021
- Number of quasi-drugs approved by PMDA Japan FY 2012-2020
- Number of BTC and OTC drugs approved by PMDA Japan FY 2012-2020
- Number of in vitro diagnostics approved by PMDA Japan FY 2012-2020
- Number of biosimilars approved by PMDA Japan 2010-2019
- Number of NME approved Japan 2012-2021
- Number of clinical trials for new drugs in South Korea 2010-2020
- U.S. drug development phase II success rates 2011-2020, by disease area
- Number of FDA approvals for CAR-T cell therapies 2012-2024
- Valid certificates (CEPs) for API quality worldwide by region 2020
Korea Drug Research Association. (July 16, 2016). Number of new drugs receiving approval status in South Korea in 2014, by therapeutic category [Graph]. In Statista. Retrieved February 03, 2023, from https://www.statista.com/statistics/646536/new-drug-approvals-south-korea-by-therapy-area/
Korea Drug Research Association. "Number of new drugs receiving approval status in South Korea in 2014, by therapeutic category ." Chart. July 16, 2016. Statista. Accessed February 03, 2023. https://www.statista.com/statistics/646536/new-drug-approvals-south-korea-by-therapy-area/
Korea Drug Research Association. (2016). Number of new drugs receiving approval status in South Korea in 2014, by therapeutic category . Statista. Statista Inc.. Accessed: February 03, 2023. https://www.statista.com/statistics/646536/new-drug-approvals-south-korea-by-therapy-area/
Korea Drug Research Association. "Number of New Drugs Receiving Approval Status in South Korea in 2014, by Therapeutic Category ." Statista, Statista Inc., 16 Jul 2016, https://www.statista.com/statistics/646536/new-drug-approvals-south-korea-by-therapy-area/
Korea Drug Research Association, Number of new drugs receiving approval status in South Korea in 2014, by therapeutic category Statista, https://www.statista.com/statistics/646536/new-drug-approvals-south-korea-by-therapy-area/ (last visited February 03, 2023)
Number of new drugs receiving approval status in South Korea in 2014, by therapeutic category [Graph], Korea Drug Research Association, July 16, 2016. [Online]. Available: https://www.statista.com/statistics/646536/new-drug-approvals-south-korea-by-therapy-area/